Company profile: Insife
1.1 - Company Overview
Company description
- Provider of life science consulting and drug safety technology, offering HALOPV, an integrated platform for end-to-end pharmacovigilance (case intake, processing, regulatory compliance); HALOPV Enterprise for large-scale cloud environments; GRIP, a global regulatory intelligence subscription; an AI case intake solution; and a PSMF module that automates Pharmacovigilance System Master Files.
Products and services
- Case Intake Solution: An AI-driven intake product automates pharmacovigilance case ingestion, transforming unstructured source data into structured, process-ready cases for downstream case processing
- HALOPV: A modular platform with integrated modules manages end-to-end pharmacovigilance, covering case intake, case processing, and regulatory compliance activities across safety operations
- HALOPV Enterprise: An enterprise-grade dedicated cloud environment version of HALOPV designed for large-scale organizations, delivering enhanced processing power and organizational control for pharmacovigilance management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Insife
ClearLight Biotechnologies
HQ: United States
Website
- Description: Provider of CLARITY tissue clearing kits for lipid clearing of soft tissues (versions for high or low lipid content), 3D IHC consulting services for CLARITY tissue clearing and 3D immunohistochemistry, an immunostaining buffer optimized for tissues cleared with CLARITY, and Tru3D AI software service for 3D spatial biology to solve quantitative research problems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClearLight Biotechnologies company profile →
ObvioHealth
HQ: United States
Website
- Description: Provider of a no-code digital platform and app for study design and patient experience visualization; a virtual site team for scheduling, televisits, and personalized participant support; clinical science experts to identify digital endpoints and assist sponsors in achieving robust outcomes; a patient engagement suite combining a mobile app and easy data capture; remote patient monitoring with real-time adverse event detection; and ePRO/eCOA tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ObvioHealth company profile →
Circuit Clinical
HQ: United States
Website
- Description: Provider of turnkey, end-to-end clinical trial solutions as an integrated research organization. Services include community research networks with traditional, hybrid, and decentralized visits; MD Prescreen led by research nurses and medical professionals; biospecimen collection; Phase I–IV trial management focused on diverse, community populations; and an IRO with direct EMR access to 2.5M+ participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circuit Clinical company profile →
Maaguzi
HQ: United States
Website
- Description: Provider of web-based and mobile Patient Reported Outcomes (PRO) and Site Reported Data Collection solutions for the life science industry, delivered via OutcomeLogix and used in therapeutic areas including Men's Health, Endocrinology, Respiratory, and CNS areas such as Depression, Anxiety, and Schizophrenia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Maaguzi company profile →
Methuselah Health
HQ: United Kingdom
Website
- Description: Provider of drug discovery solutions for ageing-related diseases, studying proteome instability and offering ProQuant, a quantitative proteomics platform to analyze proteome stability and identify novel therapeutic targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Methuselah Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Insife
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Insife
2.2 - Growth funds investing in similar companies to Insife
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Insife
4.2 - Public trading comparable groups for Insife
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →